Navigation Links
Sunshine Heart Announces IDE Approval To Begin C-Pulse U.S. Clinical Feasibility Trial
Date:9/12/2008

SYDNEY, Australia, Sept. 12 /PRNewswire/ -- Sunshine Heart (ASX: SHC), a global medical device company focused on innovative heart assist technologies, today announced that it has received conditional approval of an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin its first U.S. clinical feasibility trial for the C-Pulse(TM) device in patients with moderate heart failure. C-Pulse is an implantable aortic cuff, designed as a cost effective heart assist therapy. The device is a uniquely positioned Class III heart failure therapy that offers an innovative intervention bridging the clinical gap between heart failure pacemakers and end stage therapies which potentially creates a new market opportunity.

Enrollment is expected to begin at six premiere U.S. medical institutions by the end of 2008. The objective of the trial is to evaluate the safety and efficacy of C-Pulse in 20 patients currently suffering from moderate heart failure. William Abraham, MD, of Ohio State University, and Patrick McCarthy, MD, of Northwestern University Medical Center, will serve as national co-lead principal investigators. Each patient's performance with C-Pulse will be closely monitored over a six month follow-up period.

Following the trial's successful completion, the Company will request CE Mark approval to market C-Pulse in the E.U. and other international countries that honor CE Mark label claims for device safety. In addition, the Company will seek FDA approval for a larger randomized U.S. pivotal study to support the submission of a marketing application for C-Pulse in the U.S.

Malcolm McComas, Chairman of the Board commented, "We are proud to announce that Sunshine Heart is the first company to receive FDA approval to run a clinical trial evaluating a non-blood contacting heart assist device. The agency's clinical approval of this treatment approach for moderate heart failure raises Sunshine Heart's profile as
'/>"/>

SOURCE Sunshine Heart
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Many Heart Attack Patients Dont Get Best Emergency Treatment
2. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
3. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
4. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
5. WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development
6. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
7. Its Only Heartburn...or is it? Chronic Heartburn a Risk Factor for Precursor to Esophageal Cancer
8. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
9. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
10. Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results
11. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , Feb. 27, 2015  Finesse expands office in ... Finesse Solutions announced the expansion of its operations in ... planned for mid-March and access for customers is expected ... A-563, and located adjacent to the current office, the ... Finesse automation engineering team and allow Finesse to bring on ...
(Date:2/26/2015)... , Feb. 26, 2015  Today the National ... The psychological and physical side effects of pain medications ... painkillers, such as Vicodin and Oxycontin, are safer options ... overdose on prescription painkillers than on heroin and cocaine ... CEO of NSC. "Yet, these medications are marketed as ...
(Date:2/26/2015)... WASHINGTON , Feb. 26, 2015 Legislation ... includes a pharmacy provision to help prevent inappropriate prescriptions ... The Protecting the Integrity of Medicare Act (PIMA) ... Subcommittee Chairman Kevin Brady (R-TX) and Ranking ... the prescription drug abuse epidemic and implement the right ...
Breaking Medicine Technology:New Finesse Office in United Kingdom 2National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2
... WILMINGTON, Del. , April 30 ... and Drug Administration (FDA) has approved VIMOVO™ ... of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ... gastric ulcers in patients at risk of developing NSAID-associated ...
... The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine ... as its July 2010 "Stock to Study" and Gilead ... for investors, informational and educational use. , ... "The committee chose Teva Pharmaceutical Industries because of the tremendous ...
Cached Medicine Technology:FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 2FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 3FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 4FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 5FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 6FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 7FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 8FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 9BetterInvesting Magazine Releases July's Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 2BetterInvesting Magazine Releases July's Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 3
(Date:2/27/2015)... SACRAMENTO, Calif. (PRWEB) February 27, 2015 ... those who are documented to use Medicaid, the ... and families, according to a new study from ... that the greatest predictor of farmworker use of ... emergency care regardless of documentation status, was having ...
(Date:2/27/2015)... 2015 According to court documents, Donna ... June 25, 2013 and underwent a procedure during which ... mouth. Because the duodenoscope allegedly had not been ... “superbug” carbapenem-resistant Enterobacteriaceae (CRE). , A lawsuit ... County on behalf of Ms. Pirolli alleging that Lutheran ...
(Date:2/27/2015)... The winter season is here, and with ... mold grows, it can be harmful to the home and ... consequences of mold growth with the help of Enviro-Test. Enviro-Test, ... on the best ways to prevent mold during the winter ... conditions for mold to thrive. Mold must be removed properly, ...
(Date:2/27/2015)... Mediaplanet today announces the launch of its second ... to bring blood health and cancer awareness to the ... this edition go beyond the concept of these insidious ... research and technological strides needed to develop new solutions ... approximately every 3 minutes one person in the ...
(Date:2/27/2015)... 27, 2015 “ Logical Operations ” ... Tech Report, which takes a look at the latest ... Mallory Sofastaii, a special reporter for NewsWatch and a ... how this company helps companies avoid cyber security threats. ... they’ll probably see cyber security somewhere in the headlines. ...
Breaking Medicine News(10 mins):Health News:UC Davis Study Finds Undocumented Farmworkers Use Medicaid Half as Often as Documented Farmworkers 2Health News:UC Davis Study Finds Undocumented Farmworkers Use Medicaid Half as Often as Documented Farmworkers 3Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2Health News:Enviro-Test Offers Tips for Winter Mold Prevention 2Health News:Know Your Blood: Raising Awareness through Mediaplanet’s “Blood Health” Campaign 2Health News:A Way for Companies to Avoid Cyber Security Threats was Featured on NewsWatch Television on January 30, 2015 2
... Imaging(R),Inc., a wholly owned subsidiary of Mercury ... announced it has signed a comprehensive marketing ... 2D/3D medical imaging and,diagnostic software. Under the ... for Viatronix,s V3D-Colon(R) Virtual Colonoscopy product in ...
... PT. RICHMOND, Calif., Nov. 24 Transcept Pharmaceuticals,Inc., a ... President & Chief Executive Officer, is scheduled to,present at ... New York,City on Tuesday, December 2, 2008 at 8:00 ... An audio webcast of the presentation will be ...
... Colo., Nov. 24 LABS Inc., one of the ... added,Dr. Carol Pancoska, a leading figure in the field ... Directors. , Dr. ... of immunology for,over thirty years. She has held various ...
... Site in Southeast to Choose SafeTrace Tx(R) , ... Technologies(R), Inc. ("Global Med") (OTC Bulletin Board: GLOB), an international ... Technologies(R) ("Wyndgate") division has licensed SafeTrace Tx transfusion management software ... Louisiana. Terms of the agreement were not disclosed. ...
... Event,s Healthcare IT Summit today announced the winners of ... place last,week in San Diego, explored the challenges and ... enable care and business strategies. , ... merely transaction processing and,distributing information, CXOs and external influencers ...
... VOLC ), a leader in the development, manufacturing and sales of ... disease, said today that it will be participating in the 20th ... , The presentation by Scott Huennekens, ... Standard Time (10:30 a.m., Pacific Standard Time). , ...
Cached Medicine News:Health News:Visage Imaging and Viatronix Sign Comprehensive Marketing Agreement for Virtual Colonoscopy Product 2Health News:Visage Imaging and Viatronix Sign Comprehensive Marketing Agreement for Virtual Colonoscopy Product 3Health News:Visage Imaging and Viatronix Sign Comprehensive Marketing Agreement for Virtual Colonoscopy Product 4Health News:Transcept Pharmaceuticals, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference 2Health News:LABS Inc. Adds Dr. Carol Pancoska as Laboratory Director 2Health News:Gulf Coast Hospital Chooses Global Med Technologies(R)' Blood System 2Health News:Gulf Coast Hospital Chooses Global Med Technologies(R)' Blood System 3Health News:Gulf Coast Hospital Chooses Global Med Technologies(R)' Blood System 4Health News:Everything Channel's Vision Events Announces the Winners of the Healthcare IT Innovation(TM) Awards 2Health News:Volcano Corporation Presentation at Piper Jaffray Conference to Be Webcast 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: